China’s growth continues as country becomes clinical trial powerhouse
As China’s powerhouse status grows even bigger in the clinical trial space, industry leaders are set to come together to…
News
Context drops bispecific T-cell engager on cost-cutting initiative
BioVie stock sinks on Phase IIb Parkinson’s trial data
DSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study
First patient dosed with DISP-10 in Dispatch Bio’s cancer trial
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Summit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab
